)The top 100 stock
market authors
selected for publication in the last week
market authors
selected for publication in the last week
candewish » Comments » AMGN
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Those with the largestSee all
increase in followers
in the last week
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
Roche Covets Genentech for Good Reason [View article]
was only 11%, not 44% as stated above. Further Roche's $89/share
offer was tendered when the market price of $80/share was regarded
by most DNA investors as well below Genentech's fair value.
Wall Street's response to Roche's offer was, "Does anyone take those
penny pinching Swiss seriously??"